- Home
- BOWN vs FGEN Comparison
BOWN vs FGEN Comparison
Compare BOWN & FGEN Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- BOWN
- FGEN
- Stock Information
- Founded
- BOWN 2023
- FGEN 1993
- Country
- BOWN United States
- FGEN United States
- Employees
- BOWN N/A
- FGEN N/A
- Industry
- BOWN
- FGEN Biotechnology: Pharmaceutical Preparations
- Sector
- BOWN
- FGEN Health Care
- Exchange
- BOWN Nasdaq
- FGEN Nasdaq
- Market Cap
- BOWN 28.5M
- FGEN 33.5M
- IPO Year
- BOWN 2023
- FGEN 2014
- Fundamental
- Price
- BOWN $10.16
- FGEN $5.62
- Analyst Decision
- BOWN
- FGEN Strong Buy
- Analyst Count
- BOWN 0
- FGEN 1
- Target Price
- BOWN N/A
- FGEN $250.00
- AVG Volume (30 Days)
- BOWN 2.8K
- FGEN 60.4K
- Earning Date
- BOWN 01-01-0001
- FGEN 08-05-2025
- Dividend Yield
- BOWN N/A
- FGEN N/A
- EPS Growth
- BOWN N/A
- FGEN N/A
- EPS
- BOWN 0.32
- FGEN N/A
- Revenue
- BOWN N/A
- FGEN $6,996,000.00
- Revenue This Year
- BOWN N/A
- FGEN N/A
- Revenue Next Year
- BOWN N/A
- FGEN N/A
- P/E Ratio
- BOWN $26.97
- FGEN N/A
- Revenue Growth
- BOWN N/A
- FGEN N/A
- 52 Week Low
- BOWN $2.71
- FGEN $4.50
- 52 Week High
- BOWN $19.77
- FGEN $38.25
- Technical
- Relative Strength Index (RSI)
- BOWN 49.68
- FGEN 40.90
- Support Level
- BOWN $8.70
- FGEN $5.37
- Resistance Level
- BOWN $10.20
- FGEN $5.73
- Average True Range (ATR)
- BOWN 0.43
- FGEN 0.49
- MACD
- BOWN -0.03
- FGEN 0.03
- Stochastic Oscillator
- BOWN 70.98
- FGEN 37.56
About BOWN Bowen Acquisition Corp
Bowen Acquisition Corp is a blank check company.
About FGEN FibroGen Inc
FibroGen Inc is a biotechnology company focused on discovering, developing, and commercializing novel therapeutics to treat serious cancer biology and anemia. The company operates in one reportable segment: the development and commercialization of novel therapeutics to treat serious unmet medical needs. The company generates the vast majority of its revenue in Europe, followed by Japan. Virtually all of FibroGen's revenue to date has been generated from its collaboration agreements. FibroGen seeks partners with research, development, and marketing capabilities and other resources that strengthen the company's ability to advance product candidates. Geographically, it operates in United States, Japan, Europe and Others.